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Abstract
Stiff left atrial (LA) syndrome was initially reported in post-cardiac surgery patients and
known to be associated with low LA compliance. We investigated the physiological and clin-
ical implications of LA compliance by estimating LA pulse pressure (LApp) among patients
with atrial fibrillation (AF) and structurally and functionally normal heart. Among 1038 conse-
cutive patients with LA pressure measurements before AF ablation, we included 334
patients with structurally and functionally normal heart (81.7% male, 54.1±10.6 years,
77.0% paroxysmal AF) after excluding those with hypertension, diabetes, and previous
ablation or cardiac surgery. We measured LApp (peak-nadir LA pressure) at the beginning
of the ablation procedure and compared the values with clinical parameters and the AF
recurrence rate.AF patients with normal heart were younger and more frequently male and
had paroxysmal AF, a lower body mass index, and a lower LApp compared to others (all
p<0.05).Based on the median value, the low LA compliance group (LApp13mmHg) had a
smaller LA volume index and lower LA voltage (all p<0.05) compared to the high LA compli-
ance group. During a mean follow-up of 16.7±11.8 months, low LA compliance was inde-
pendently associated with two fold-higher risk of clinical AF recurrence (HR:2.202; 95%
CI:1.077–4.503; p = 0.031).Low LA compliance, as determined by an elevated LApp, was
associated with a smaller LA volume index and lower LA voltage and independently associ-
ated with higher clinical recurrence after catheter ablation in AF patients with structurally
and functionally normal heart.
Introduction
Stiff left atrial (LA) syndrome, was initially reported by Pilote et al. in 1988, presenting as
severe pulmonary hypertension 7 years after mitral valve surgery.[1]In their report, cardiac
catheterization revealed a marked V wave without any mitral prosthetic valve dysfunction or
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regurgitation. Thus, stiff LA syndrome has generally been defined as pulmonary hypertension
that develops long after cardiac surgery without any other cardiac cause.[1]However, this syn-
drome regained attention in patients who had undergone catheter ablation for atrial fibrillation
(AF), especially after multiple ablation procedures.[2]Although there have been reports of
more extensive ablation, resulting in better clinical outcomes in patients with persistent AF
(PeAF),[3] more touches may reduce LA compliance. Consequently, pulmonary hypertension
after catheter ablation is detected in 1.4% of patients without pulmonary vein (PV) stenosis. It
is also reported to occur more in patients with previous LA scarring and small LA dimensions.
[2]Recently, we reported that high LA pressures are associated with both advanced electroana-
tomical remodeling of LA and independent predictors for clinical recurrence of AF after cathe-
ter ablation.[4]However, it is unclear whether LA compliance has some clinical implication in
patients who underwent radiofrequency catheter ablation (RFCA). Therefore, we hypothesized
that the reduced LA compliance itself may contribute to the pathophysiology of AF, even
though it is not as extreme as stiff LA syndrome. Considering that AF is a multifactorial disease
associated with degenerative processes, such as aging, hemodynamic factors, and metabolic
factors, we tested our hypothesis in AF patients without hypertension, diabetes, or associated
cardiac disease, after excluding for other confounding factors. We also attempted to identify
factors that contributed to LA compliance. Although there are several different indirect ways to
estimate LA compliance,[5,6] we quantified LA compliance by directly measuring the LA pulse
pressure (LApp) at the beginning of the procedure and assumed minimal change in LA vol-
ume.[5–7]
Material and Methods
Study population
The study protocol adhered to the Declaration of Helsinki and was approved by the Institu-
tional Review Board of Yonsei University Health System. All patients provided written
informed consent. From1038 consecutive patients with LA pressure measurements in the Yon-
sei AF Ablation Cohort (June 2009 to December 2013), we identified 334AF patients with
structurally and functionally normal heart after excluding certain patients due to hemody-
namic and metabolic factors. The study’s exclusion criteria were as follows: 1) permanent AF
refractory to electrical cardioversion; 2) associated hypertension, diabetes, or congestive heart
failure; 3) E/Em>15 suggesting left ventricular (LV) diastolic dysfunction; 4) AF with any
valvular disease (including mild-degree disease); 5) structural heart disease; 6) coronary artery
disease with luminal narrowing of more than 50% or history of percutaneous coronary inter-
vention; 7) prior cardiac surgery or AF catheter ablation; and 8)unmeasurable LA pressure
(LAP) during sinus rhythm due to frequent re-initiation of AF. The majority (76.6%) of the
patients had paroxysmal AF (PAF), and 23.4% had PeAF. Three-dimensional (3D) spiral com-
puterized tomography (CT) scans (64 Channel, Light Speed Volume CT, Philips, Brilliance 63,
Netherlands) were performed to define the pulmonary vein (PV) anatomy. All antiarrhythmic
drugs were discontinued for a period corresponding to at least five half-lives. Anticoagulation
therapy was maintained prior to catheter ablation.
Echocardiographic evaluation of the heart
All patients underwent transthoracic echocardiography prior to RFCA. Chamber size (LA vol-
ume index [LAVI], LA dimension, LV wall thickness, and LV mass index [LVMI]), transmitral
flow velocity (E wave, A wave), and tissue Doppler images of the mitral annular septal area
(peak diastolic velocity [Em] and peak systolic velocity [Sm]) were acquired according to the
American Society of Echocardiography guidelines (Fig 1A).The index was calculated as divided
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by body surface area (BSA). Transesophageal echocardiography (TEE) was performed in order
to exclude intracardiac thrombi and measure the emptying velocity of the LA appendage in all
patients prior to ablation using the average derived from five consecutive beats.
Left atrial pressure measurement
Intracardiac electrograms and hemodynamic measurements were recorded using the Prucka
Cardio LabTM electrophysiology system (General Electric Medical Systems Inc., Milwaukee,
WI, USA). A double transseptal puncture approach was used for catheter access to the LA.
LAP was measured during both sinus rhythm and AF immediately after transseptal puncture
using a 6-Fr pigtail catheter (A&AMedical Device Inc., Gyeonggi-do, Republic of Korea) that
was inserted into the LA via a long sheath (Schwartz left 1, St. Jude Medical Inc., Minnetonka,
MN, USA).[4] If the initial rhythm was AF, we measured LAP insinus rhythm after internal
cardioversion (2–10J biphasic shocks, Lifepak12, Physiocontrol Ltd.). We then measured LAP
after waiting at least 3 minutes until recovery from atrial stunning by cardioversion. If we failed
to maintain sinus rhythm after three cardioversion attempts, we excluded the patient from the
study. We analyzed LAPpeak (v wave), LAPnadir (xwave), and LAPmeanfor 10 consecutive cycles
in sinus rhythm, and the results were averaged.[6] LA pulse pressure (LApp) was calculated by
subtracting LAPnadir from LAPpeak (the difference between LAPpeak and LAPnadir, Fig 1B).Atrial
compliance was calculated asΔV/ΔP.[5,6] Several previous studies indirectly measured LA vol-
ume using different echocardiographic techniques.[5,6]However, precise and instantaneous
measurement of LA volume change and pressure is technically challenging due to the
Fig 1. (A) Tissue Doppler images of the mitral annular septal area (peak diastolic velocity [Em]) and the flow velocity of mitral inflow were acquired.
Patients with E/Em>15, suggesting left ventricular (LV) diastolic dysfunction, were excluded. (B) LAPpeak (v wave), LAPnadir (x wave), and LAPmean
were measured during sinus rhythm, and LA pulse pressure (LApp) was calculated by subtracting LAPnadir from LAPpeak (the difference between
LAPpeak and LAPnadir).
doi:10.1371/journal.pone.0143853.g001
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complexity of LA geometry. Therefore, we defined and quantified LA compliances through
direct measurement of LApp and assumed a minimal change in LA volume based on the previ-
ous physiologic studies.[5–7]The representation of aortic compliance by aortic pulse pressure
was based on the same rationale.[8]
Electroanatomical mapping and LA CTmeasurement
A 3D electroanatomical map (NavX, St. Jude Medical Inc., Minnetonka, MN, USA) was generated
using a circular PVmapping catheter (Lasso; Biosense-Webster Inc., Diamond Bar, CA, USA).
NavX-system-generated 3D geometries of the LA and PVs were merged with the corresponding
3D spiral CT images. We generated LA voltage maps by obtaining contact bipolar electrograms
from 350–500 points on the LA endocardium during atrial pacing at 500ms and calculated the
mean LA voltage as previously described.[9]LA voltage was measured at a point of secure endo-
cardial contact by experienced operators after circumferential PV isolation. Contact artifacts,
noises, and isolated PV area were excluded in voltage analysis. A technician who was blinded to
the clinical information, analyzed the color-coded CT-merged NavX voltage maps with custom-
ized software (Image Pro, Media Cybernetics, Inc., Rockville, MD, USA).[9,10] The 3D spiral CT
images of the LA were analyzed on an imaging processing workstation (Aquarius, Terarecon Inc.,
Foster City, CA, USA). For the regional volumetric analyses, each LA image was subdivided
according to embryological origin as follows: venous LA, anterior LA, and LA appendage.[9]
Radiofrequency catheter ablation
An open irrigated 3.5-mm-tip deflectable catheter (Celsius, Johnson & Johnson Inc., Diamond
Bar, CA, USA; Coolflex, St. Jude Medical Inc., Minnetonka, MN, USA; 30–35 W; 47°C) was
used for RFCA. All patients initially underwent circumferential PV isolation and cavotricuspid
isthmus block. For the patients with PeAF, we added a roof line, a posterior inferior line, and
an anterior line to the standard lesion set. Additional ablations of the superior vena cava, non-
PV foci, and complex fractionated electrograms were conducted at the operator’s discretion.
The procedure ended when there was no immediate recurrence of AF after cardioversion with
isoproterenol infusion (5–10μg/min). If there were mappable AF triggers or atrial premature
beats, we carefully mapped and ablated these non-PV foci as much as possible.
Post-ablation management and follow-up
All patients were followed, and antiarrhythmic drugs were discontinued after RFCA. Patients
visited an outpatient clinic regularly at 1, 3, 6, and 12 months and then every 6 months or
whenever symptoms occurred after RFCA. All patients underwent electrocardiography (ECG)
at every visit and 24- or 48-hour Holter recording or event recording at 3, 6, and every 6
months, following the 2012 Heart Rhythm Society (HRS) / European Heart Rhythm Associa-
tion (EHRA) / European Cardiac Arrhythmia Society (ECAS) Expert Consensus Statement
guidelines. However, whenever patients reported palpitations, Holter monitor or event moni-
tor recordings were obtained and evaluated for possible recurrence of arrhythmia. We defined
recurrence of AF as any episode of AF or atrial tachycardia of at least 30 sec in duration. Any
ECG documentation of AF recurrence after 3 months was diagnosed as clinical recurrence.
Data analysis
Normally-distributed continuous variables are expressed as mean ± standard deviation (SD).
We compared LAP during both sinus rhythm and AF using the degree of electroanatomical
remodeling of the LA, echocardiographic parameters reflecting hemodynamic status, and
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clinical outcomes. Statistical significance of the comparisons was assessed using a student t-test
and χ2 test. And uni- and multi-variate logistic regression analyses were used to analyze the
association between clinical parameters and LApp. Variables selected for multivariate analysis
were those with p-value<0.05 on univariate analysis or with having association with AF recur-
rence clinically. And if there was significant correlation between selected variables (R>0.5), only
one variable was used to avoid multicolinearity for multivariate regression analysis. Log minus
log (LML) graph for analyzing the proportionality assumption of LApp shows parallel pattern
according to groups of LApp. This means that the effects of LApp are constant regardless of time
(the proportional assumption of Cox regression analysis). The cut off value for LApp, which best
differentiate recurrence and no recurrence, was determined by an algorithm of maximization of
hazard ratio,[11] this cut off value is identical with median (LApp = 13mmHg). Kaplan-Meier
and Cox regression analysis were used to analyze AF-free survival after catheter ablation. Vari-
ance inflation factors (VIF)10 were considered as indicating co-linearity and were excluded in
multivariate linear regression. A p-value<0.05 was considered statistically significant.
Results
Clinical characteristics of AF with structurally and functionally normal heart
Among the 1038 patients, 334 patients (32.2%)were classified as having AF with structurally
and functionally normal heart after excluding any structural heart disease, hypertension, and
diabetes (Table 1).
We intentionally excluded patients with diabetes to rule out metabolic factors affecting LA
compliance; however, the results were consistent when the patients with diabetes (n = 21) were
included in the normal heart AF group (S1 Table).Patients in the normal heart AF group were
younger and more likely to be male and to have paroxysmal AF (all p<0.001). Additionally,
patients in the normal heart AF group had a lower body mass index (BMI) than other AF
patients, and LApp in the normal heart AF group was significantly lower than in other AF
patients (all p<0.05; Table 1).
Low LA volume index and low LA voltage in AF with reduced LA
compliance
For the 334normal heart AF patients, we defined low LA compliance as LApp13mmHg,
based on the median value of LApp (Table 2). The cut off value by median is identical with
value calculated by an algorithm of maximization of hazard ratio (LApp = 13mmHg).[11]
Heart rate was not significantly different at the time of LAP measurement between the groups
with high and low LApp. Both the LA volume index measured by 3D-CT and mean LA voltage
were lower in patients with LApp13mmHg than in those with LApp<13mmHg (both
p<0.05; Table 2, Fig 2).
In the multivariate logistic regression analysis, low LA voltage was independently associated
with low LA compliance (LApp13mmHg) after adjusting age, gender, AF type, and LA vol-
ume (OR = 0.395;95% CI: 0.168–0.928;p = 0.033;Table 3).
Low LA compliance is independently associated with post-ablation AF
recurrence
During a mean follow-up of16.7±11.8 months (range, 3 to 47 months), high LApp13mmHg
(HR 2.202; 95% CI: 1.077–4.503; p = 0.031), early recurrence (HR 2.083; 95% CI: 1.042–4.166;
p = 0.038) and mean LA voltage (HR 0.46; 95% CI: 0.249–0.850; p = 0.013) were strong predic-
tors of clinical AF recurrence after RFCA, independent of age, gender, and AF type (Table 4).
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These results were also consistent in an analysis that included patients with diabetes (S2
Table). Kaplan-Meier analysis for AF-free survival also showed a significantly higher rate of
clinical recurrence in patients with high LApp (low LA compliance) than in those with low
LApp (high LA compliance; Log Rank: p = 0.038; Fig 3).
Discussion
In the current study, we explored the clinical significance of reduced LA compliance based on
LApp in AF patients with structurally and functionally normal heart to exclude confounding
hemodynamic (valvular disease, structural disease, and left ventricular systolic and diastolic
dysfunction) [4,12] and metabolic factors (hypertension and diabetes). [13] Low LA compli-
ance was related to a low LA volume index and independently associated with low LA voltage,
suggesting LA substrate remodeling without LA enlargement. Low LA compliance was found
to be a predictor of clinical recurrence after catheter ablation for AF in structurally and func-
tionally normal heart AF independent of age, gender, and AF type.
Reduced LA compliance and LA pulse pressure
Stiff LA syndrome has been defined as dyspnea with associated pulmonary hypertension that
occurs in the setting of increased LAPs following cardiac surgery. Extensive AF catheter abla-
tion associated with large atrial scars was also reported to be an independent predictor for stiff
LA syndrome, [2] although the incidence was very low (1.4%). [3] However, a clear-cut defini-
tion and mechanism for LA stiffness in AF patients with structurally and functionally normal
Table 1. Clinical characteristics of patients.
All Normal heart AF (n = 334) Others p-value
(n = 1038) (n = 704)
Male (n,%) 771 (74.3%) 273 (81.7%) 498 (70.7%) <0.001
Age (years) 57.7±11.2 54.1±10.6 59.5±11.1 <0.001
PAF (n,%) 704 (67.8%) 256 (76.6%) 448 (63.6%) <0.001
BSA (m2) 1.8±0.2 1.8±0.2 1.8±0.2 0.053
BMI (kg/m2) 24.9±3.1 24.6±2.7 25.0±3.2 0.041
CHA2DS2VASc score 1.5±1.4 0.6±1.0 2.0±1.4 <0.001
Heart Failure (n,%) 89 (8.6%) 0 89 (12.6%) NA
Hypertension (n,%) 488 (47.0%) 0 488 (69.3%) NA
Age75 (n,%) 50 (7.1%) 4 (1.2%) 46 (6.5%) <0.001
Diabetes (n,%) 140 (13.5%) 0 140 (19.9%) NA
Stroke/TIA (%, n) 125 (12.0%) 24 (7.2%) 101 (14.3%) <0.001
Associated structural heart disease* 261 (37.1%) 0 261 (37.1%)
Coronary artery disease (n,%) 142 (20.2%) 0 142 (20.2%) NA
Valvular heart disease (n,%) 75 (10.7%) 0 75 (10.7%) NA
HCMP (n,%) 20 (2.8%) 0 20 (2.8%) NA
DCMP (n,%) 17 (2.4%) 0 17 (2.4%) NA
Congenital heart disease (n,%) 17 (2.4%) 0 17 (2.4%) NA
LApp (mmHg) 15.3±7.6 14.0±6.1 16.0±8.3 <0.001
PAF, paroxysmal atrial ﬁbrillation; BSA, body surface area; BMI, body mass index; DCM, dilated cardiomyopathy; HCMP, hypertrophic cardiomyopathy;
TIA, transient ischemic attack; LApp, left atrial pulse pressure
*, There are some overlapping of multiple structural heart diseases in the same patients.
doi:10.1371/journal.pone.0143853.t001
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heart without cardiac intervention have not yet been clearly determined, despite not being as
extreme as stiff LA syndrome. In the current study, we explored the mechanisms of LA stiffness
and reduced LA compliance in patients with normal heart AF after excluding hemodynamic,
metabolic factors and. And we utilized LApp to represent the LA compliance, similar to the use
of aortic pulse pressure as an indicator of aortic compliance.[8]In general, LA compliance can
be calculated as the ratio of the change in LA volume to the change in LA pressure (LApp);
[5,6] however, precise and instantaneous measurements of LA volume change and pressure are
challenging. Therefore, we represented and quantified LA compliance using directly measured
LApp, assuming minimal change in LA volume based on previous physiologic studies.[5–7]To
minimize confounding factors affecting LA volume, we enrolled AF patients with normal LV
systolic and diastolic function and measured LApp at the beginning of the procedure after an
overnight fast. As this study was not targeted for symptomatic stiff LA syndrome, there was no
gold standard for a threshold LApp that would suggest a reduced LA compliance. However,
our definition for reduced LA compliance based on the median value of LApp was a good
representation of the degree of LA remodeling and clinical recurrence of AF.
Table 2. Baseline characteristics of patients according to the LA compliance.
All LApp (SR)13mmHg LApp (SR)<13mmHg p-value
(n = 334) (n = 186) (n = 148)
Heart rate at LApp (bpm) 59.4±9.5 59.2±10.1 59.6±8.6 0.731
Male (%) 81.7 80.1 83.8 0.389
Age (years) 54.1±10.6 54.3±10.5 53.8±10.8 0.645
PAF (%) 76.6 79 74.3 0.312
BSA (m2) 1.8±0.2 1.8±0.2 1.8±0.2 0.206
BMI (kg/m2) 24.6±2.7 24.3±2.7 24.9±2.7 0.053
Stroke/TIA (%, n) 7.2 8.1 6.1 0.487
Echocardiogram
LA dimension (mm) 39.7±5.6 39.4±5.5 40.1±5.6 0.262
LA volume index (ml/m2) 30.8±9.6 30.2±9.1 31.5±10.2 0.230
LV ejection fraction (%) 63.9±6.4 63.7±6.0 64.3±6.9 0.406
E/Em 8.5±2.5 8.5±2.5 8.6±2.4 0.655
LVMI (g/m2) 88.3±18.3 87.1±17.7 90.0±19.0 0.228
LAA emptying velocity (cm/s) 56.0±22.8 56.8±21.4 55.2±24.1 0.631
3D-CT
LA volume/BSA (ml/m2) 75.4±19.8 73.1±19.9 78.4±19.3 0.035
Anterior LA/BSA (ml/m2) 43.3±13.7 42.1±13.5 44.9±14.0 0.101
LAA/BSA (ml/m2) 6.7±3.2 6.5±3.0 7.0±3.5 0.229
NavX Voltage Map (n = 123)
Mean LA voltage (mV) 1.3±0.7 1.2±0.6 1.4±0.8 0.032
Mean LAA voltage (mV) 2.5±1.6 2.3±1.5 2.8±1.7 0.039
BNP (pmol/L) 365.6±289.0 354.9±282.7 380.6±298.0 0.455
Conduction Velocity (m/sec) 0.5±0.4 0.5±0.4 0.6±0.4 0.293
Ablation time (sec) 4815.2±1456.3 4724.2±1492.6 4929.8±1406.0 0.203
Procedure time (min) 185.3±44.5 181.7±43.1 189.8±45.9 0.100
Follow-up duration (months) 16.7±11.8 15.9±12.5 17.8±10.9 0.862
SR, sinus rhythm; LApp, left atrial pulse pressure; PAF, paroxysmal atrial ﬁbrillation; BSA, body surface area; BMI, body mass index; TIA, transient
ischemic attack; LA, left atrium; LV, left ventricle; LVMI, left ventricular mass index; LAA, left atrial appendage; BNP, B-type natriuretic peptide.
doi:10.1371/journal.pone.0143853.t002
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Actually, we tested echocardiographically measured LA capacitance.[14] Although it has
negative correlation with LApp (r = -0.477, p<0.001), it did not predict AF recurrence after
catheter ablation (median 3.1 mL/mmHg, Log rank p = 0.395). We also calculated atrial con-
traction by the analysis of LA ejection force in 123 patients whose echocardiogram was mea-
sured during sinus rhythm.[15] We think it may be due to the limitation of LA volume
measurement by echocardiogram that is dependent on complex geometry, volume status, and
rhythm status. However, the patients with high LApp tended to show low LA ejection force
(8.6±5.3 vs. 10.5±6.4 kdynes, p = 0.086), and low LA ejection force was associated with high
recurrence of AF (HR 0.215, 95% CI 0.054–0.854, p = 0.029).
Clinical implications of low LA compliance
There are individual differences in the degree of LA remodeling among patients with similar
AF durations or AF burdens.[10] LA volume and voltage were variable after adjusting for
age, sex, AF type, duration, and other clinical factors in this study and previous studies.[10]
Fig 2. Typical examples of patients with low (A) or high (B) LA compliance. (Electroanatomical mapping was performed during high right atrial pacing
500ms.) Patients with low LA compliance (A) have relatively smaller LA volume and lower endocardial voltage than patients with high LA compliance and
show poor clinical outcome of AF after RFCA.
doi:10.1371/journal.pone.0143853.g002
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Recently, we reported the importance of hemodynamic factors in LA remodeling, which are
associated with AF.[4,16]High LAPpeak is related to greater LA volume, lower LA voltage, and
LV diastolic dysfunction in patients who have undergone AF catheter ablation, and it is also
associated with a higher rate of clinical recurrence.[4]Although low LA compliance estimated
by LApp was associated with low LA voltage and the recurrence of AF after RFCA in the
Table 3. Multivariate regression analysis of factors related to low LA compliance (LApp 13mmHg).
Univariate analysis Multivariate analysis
OR 95% CI p-value OR 95% CI p-value
Age 1.005 0.985–1.026 0.644 1.002 0.971–1.035 0.881
Male 0.779 0.442–1.373 0.388 0.697 0.283–1.717 0.433
Persistent AF 0.768 0.461–1.280 0.311 0.622 0.273–1.419 0.259
BSA (m2) 0.458 0.137–1.537 0.206
BMI (kg/m2) 0.923 0.851–1.001 0.054
LA dimension (Echo) 0.978 0.940–1.017 0.262
LA volume index (Echo) 0.986 0.963–1.009 0.23
LV ejection fraction 0.986 0.953–1.020 0.405
E/Em 0.98 0.899–1.069 0.654
LAA emptying velocity 1.003 0.991–1.016 0.629
LA volume index (3D-CT) 0.986 0.974–0.999 0.036 0.983 0.966–1.001 0.069
Mean LA voltage (NavX) 0.666 0.460–0.964 0.031 0.395 0.168–0.928 0.033
Mean LAA voltage 0.841 0.715–0.991 0.038 1.048 0.749–1.467 0.784
BSA, body surface area; BMI, body mass index; LA, left atrium; LV, left ventricle; LAA, left atrial appendage. OR, odds ratio; CI, conﬁdence interval
doi:10.1371/journal.pone.0143853.t003
Table 4. Multivariate Cox regression analysis of clinical AF recurrence after RFCA
Univariate analysis Multivariate analysis
HR 95% CI p-value HR 95% CI p-value
Age 1.001 0.977–1.026 0.919 0.996 0.964–1.028 0.79
Male 1.153 0.583–2.280 0.682 1.798 0.662–4.886 0.25
Persistent AF 1.364 0.766–2.428 0.291 3.099 1.054–9.117 0.04
BSA (m2) 0.777 0.186–3.243 0.73
BMI (kg/m2) 0.993 0.903–1.091 0.883
LA dimension (Echo) 1.046 1.001–1.093 0.044 1.05 0.983–1.122 0.146
LA volume index (Echo) 1.022 0.998–1.047 0.068
LV ejection fraction 1.002 0.964–1.041 0.935
E/Em 0.981 0.882–1.091 0.718
LAA emptying velocity 0.996 0.979–1.013 0.627
LA volume index (3D-CT) 1.003 0.989–1.018 0.647
LAA volume index (3D-CT) 1.031 0.939–1.132 0.523
Mean LA voltage 0.528 0.310–0.899 0.019 0.46 0.249–0.850 0.013
Mean LAA voltage 0.827 0.663–1.031 0.091
Ablation time 1 1.000–1.000 0.026 1 1.000–1.001 0.034
Early recurrence 2.935 1.749–4.927 <0.001 2.083 1.042–4.166 0.038
LApp13mmHg 1.773 1.022–3.075 0.042 2.202 1.077–4.503 0.031
BSA, body surface area; BMI, body mass index; LA, left atrium; LV, left ventricle; LAA, left atrial appendage; LApp, left atrial pulse pressure.
doi:10.1371/journal.pone.0143853.t004
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current study, LA volume was smaller in normal heart AF patients with reduced LA compli-
ance, possibly indicating the early stage of atrial myopathy before LA enlargement. Low endo-
cardial voltage has been known to be an indicator of changes in the cardiac matrix or
myocardial scars.[17,18] Therefore, LA scarring may result in low LA compliance and poor
clinical outcomes of AF catheter ablation in patients without hemodynamic burden or LA
enlargement. This finding is consistent with results of the DECAAF (Delayed Enhancement–
MRI determinant of successful Catheter Ablation of Atrial Fibrillation) study, which showed
Fig 3. Patients with low LA compliance (LApp13mmHg) have a higher recurrence rate than those with high LA compliance.
doi:10.1371/journal.pone.0143853.g003
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poor clinical outcomes of AF ablation in the group with extensive atrial scarring.[19] Extensive
RFCA for AF generates atrial scarring,[20] and a long ablation duration is an independent risk
factor for poor clinical outcomes in patients with PeAF. [21] Therefore, there is a need to
search for effective antiarrhythmic therapy that avoids extensive tissue scarring caused by
aggressive ablation.
Limitations
This study was an observational cohort study conducted on patients in a registry that included
a highly selective group of patients referred for AF catheter ablation. The change in LA volume
was not measured to estimate LA compliance, as mentioned above. Instead, we quantified LA
compliance by directly measuring LApp and assumed a minimal change in LA volume based
on previous physiologic studies. [5–7] Although we excluded other structural and hemody-
namic factors as much as possible, we did not exclude sleep apnea, and there was no age limita-
tion (mean age: 58 [18–85] years old). Low LA compliance can be either a perpetuating factor
or a result of AF, and further study with atrial tissue characterization by cardiac MRI might be
valuable. We measured LAP after cardioversion if the initial rhythm was AF (23%). LApp may
have been affected by atrial stunning, despite waiting at least 3minutes after cardioversion, and
there was no significant difference between LApp with and without cardioversion (14.5±7.4
mmHg vs. 13.9±5.6mmHg; p = 0.472).We think it is not possible to exclude potential stunning
even in patients with paroxysmal AF who showed initial sinus rhythm at the beginning of the
procedure. LApp for predicting LA compliance is an invasive parameter, and noninvasive tests
[4,22] should be validated as alternatives for wider clinical application of LA compliance in
appropriate patient selection for RFCA. Given that the endocardial voltage was measured by
point-by-point contact mapping (350–500 points), the voltage map may not represent a spa-
tially homogenous distribution of endocardial voltage. The 3D voltage map analysis was per-
formed with 2D measurements.
Conclusions
Reduced LA compliance estimated by high LApp was associated with a low LA volume index
and independently associated with low LA voltage, suggesting LA substrate remodeling with-
out LA enlargement. Low LA compliance was an independent predictor of clinical AF recur-
rence after catheter ablation in AF patients with structurally and functionally normal heart.
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